SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the main focus, with management saying the application is in final review and reaffirming confidence in the therapy. Traders are reading comments about possible labeling as encouraging, fueling bullish positioning and short-squeeze speculation, while others stress that approval remains uncertain and the decision is a binary risk.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention after reporting record quarterly revenue and its first positive adjusted EBITDA, with traders focused on Quake AIs contribution and the companys shift toward AI infrastructure. Many are bullish and anticipating a short squeeze, while others question cash needs, financing and data-center expansion timelines.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras positive Phase 2 results for ABCL635, its investigational treatment for menopausal hot flashes, alongside upbeat management comments, analyst target increases and new pipeline programs, are driving attention. Many traders see substantial potential, while others are frustrated by the stocks weak reaction and emphasize that durability data and progress toward Phase 3 remain key tests.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA for sonelokimab in hidradenitis suppurativa and the pending FDA filing-review decision dominate discussion, alongside the drugs clinical prospects. Traders are divided between optimism about the pipeline and a potential buyout, and concerns about regulatory risk, competition, and the cost of commercializing the drug independently.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A hotter-than-expected CPI reading has lifted the dollar and Treasury yields, while renewed Fed rate-hike bets weigh on gold and GLD. Traders are divided between calling the decline a deeper selloff and looking for a rebound or buying opportunity, with some questioning golds safe-haven behavior.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels sharp, sustained decline and underperformance versus uranium and rare-earth peers dominate discussion. Traders point to dilution and funding concerns, risks around the VAC acquisition and capital-intensive rare-earth expansion, and broader market and China-trade uncertainty; bullish investors are still accumulating on the long-term uranium and domestic supply-chain thesis, while bears question execution and shareholder value.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUEs strong initial commercial launch and better-than-expected product revenue are driving attention, but RVMD shares have sold off sharply despite the upbeat results. Traders are debating whether the decline reflects profit-taking and concerns about launch durability and rising expenses or an overreaction to the companys early commercial momentum.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

Cardinals steep selloff is being attributed mainly to concerns over its Hughes Brothers acquisition, with traders questioning the deals cost, potential dilution, and managements handling of margins and capital allocation. Some also point to securities-law investigations and loss of investor confidence, while bullish traders argue the shares are oversold and undervalued.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A broad semiconductor rebound tied to CoreWeaves strong results and renewed confidence in AI-infrastructure demand has lifted AMD. Traders are cheering AMDs strength and some see money rotating from Nvidia, while others warn the rapid rally may be overextended and expect profit-taking.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

A strong Q3 report, raised outlook and record backlog sparked a sharp rally, with the CEOs cancellation of his planned stock-sale program adding to bullish sentiment and talk of short covering. Traders remain divided: bulls point to robust AI-compute demand and customer prepayments, while skeptics focus on heavy debt, financing costs and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XXII Anyone HODLing this overnite or you taking profits today?

StockTwits Web

22nd Century Group Inc

 Anyone HODLing this overnite or you taking profits today?

daddy o peffercorn

@pofo   Yes, I have 1 share, holding until bankruptcy

   Yes, I have 1 share, holding until bankruptcy